CUTTING EDGE INNOVATION TO FIND
A BETTER TOMORROW
R&D Centres
Our research team across our R&D centres comprises of several highly qualified scientists with expertise in formulation and analytical development and discovery of NCEs.
Sinnar
The formulation R&D centre based at Sinnar, Maharashtra, India is Glenmark’s first R&D centre in India and is spread over 30,000 sq. ft. It is focused on Formulations Development & Analytical Research of Specialty and Branded Formulations for Global markets across dosage forms for therapeutic areas like Respiratory, Dermatology, Oncology, Cardiovascular, Anti-diabetes etc. It facilitates the research of Aerosols of various indications (MDIs, DPIs, Nebulizers and Nasal sprays) through some of the best experimental apparatus in the country.
Taloja
Spread over 1,07,000 sq. ft. the R&D Centre in Taloja, on the outskirts of Mumbai, India is focused on identifying filing opportunities by doing effective product selection and patent landscaping with a vertical integration of API. The R&D unit works in co-ordination with the Intellectual Property Management team to develop cost effective and patent driven Generic Formulations. The centre is equipped for research on a variety of dosage forms such as oral solid dosages, semi-solids, parenteral (Complex Injectable & Liposomal Products) and aerosols for various indications.
Mahape
Spread over 1,27,000 sq. ft, the R&D Centre at Mahape on the outskirts of Mumbai, India has end-to-end capabilities for discovery and development of New Chemical Entities (NCEs) from target selection to clinical development. The research facility is equipped with modern infrastructure required to carry out research activities like process & analytical chemistry, bulk actives, discovery, invitro and invivo, tissue culture, toxicology, antibody, pharmacokinetics supported by project management, clinical, regulatory affairs and IPM.
